[Acute myeloid leukemia: from risk-adapted to genotype-specific therapy]

Dtsch Med Wochenschr. 2011 Aug;136(31-32):1577-80. doi: 10.1055/s-0031-1281556. Epub 2011 Aug 1.

[Article in German]

Authors

S Kayser¹, R F Schlenk

Affiliation

¹ Klinik für Innere Medizin III, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081 Ulm.

PMID: 21809245
DOI: 10.1055/s-0031-1281556

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
DNA Methylation / drug effects
DNA Methylation / genetics
DNA Mutational Analysis
Genetic Markers / genetics
Genotype*
Humans
Leukemia, Myeloid, Acute / classification
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / genetics*
Prognosis
Randomized Controlled Trials as Topic
Remission Induction
Risk Assessment
Signal Transduction / genetics

Substances

Genetic Markers